Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI116548

Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene.

T Nakajima, H Aono, T Hasunuma, K Yamamoto, I Maruyama, T Nosaka, M Hatanaka, and K Nishioka

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Nakajima, T. in: JCI | PubMed | Google Scholar

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Aono, H. in: JCI | PubMed | Google Scholar

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Hasunuma, T. in: JCI | PubMed | Google Scholar

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Yamamoto, K. in: JCI | PubMed | Google Scholar

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Maruyama, I. in: JCI | PubMed | Google Scholar

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Nosaka, T. in: JCI | PubMed | Google Scholar

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Hatanaka, M. in: JCI | PubMed | Google Scholar

Division of Rheumatology and Molecular Immunology, St. Marianna University, Kawasaki, Japan.

Find articles by Nishioka, K. in: JCI | PubMed | Google Scholar

Published July 1, 1993 - More info

Published in Volume 92, Issue 1 on July 1, 1993
J Clin Invest. 1993;92(1):186–193. https://doi.org/10.1172/JCI116548.
© 1993 The American Society for Clinical Investigation
Published July 1, 1993 - Version history
View PDF
Abstract

One of the salient pathological features of rheumatoid arthritis is synovial cell proliferation with bone erosion. Despite extensive investigation, the factors essential for synovial cell proliferation remain to be identified. Recent studies suggest that human T cell leukemia virus type I (HTLV-I) may play an important role in synovial overgrowth observed in patients with one type of chronic inflammatory synovitis. In order to confirm and extend these observations, we have established synovial cell clones (SCCs) from three HTLV-I carriers who demonstrated synovial overgrowth but were otherwise asymptomatic. HTLV-I proviral DNA randomly integrated into the cellular genome was present in 20-30% of SCCs. The SCCs carrying HTLV-I proviral DNA and expressing the tax gene exhibited high levels of proliferative potential. HTLV-I was found to function as a transcriptional trans-activator in these SCCs. Moreover, transfection of the tax expression plasmid into SCCs resulted in the same phenotype of increased proliferation and cytokine expression as exhibited by HTLV-I provirus-carrying and tax-expressing SCCs. These data suggest that tax plays a critical role not only in leukemogenesis but also in synovial overgrowth in humans.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 186
page 186
icon of scanned page 187
page 187
icon of scanned page 188
page 188
icon of scanned page 189
page 189
icon of scanned page 190
page 190
icon of scanned page 191
page 191
icon of scanned page 192
page 192
icon of scanned page 193
page 193
Version history
  • Version 1 (July 1, 1993): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts